ITRI’s Biomedical Technology and Device Research Laboratories focuses on smart healthcare, pharmaceutical R&D, and biomedical big data, integrating interdisciplinary research capabilities to build a healthier Taiwan.
As populations age, disease patterns evolve, and medical technologies advance rapidly, biomedical innovation is increasingly critical to healthcare resilience, technological self-reliance, and industrial competitiveness. Taiwan is strengthening its R&D capabilities and leveraging its strengths in technology, manufacturing, and healthcare to drive the next wave of biomedical innovation.
As a national-level R&D organization, ITRI’s Biomedical Technology and Device Research Laboratories focuses on three strategic areas: smart healthcare, drug development, and biomedical big data. By integrating biomedicine, materials, engineering, AI, ICT, and precision manufacturing, the Laboratories bridges clinical, industrial, and international resources to develop critical technologies and R&D platforms, and accelerate innovation from technology validation to clinical application and commercialization.
From critical medicines and advanced medical devices to smart healthcare solutions, the Laboratories builds the next-generation capabilities for Taiwan’s biomedical sector. Through forward-looking R&D and cross-disciplinary innovation, the Laboratories addresses emerging healthcare needs, drives industrial innovation and upgrading, and strengthens Taiwan’s biomedical capabilities and global competitiveness.
Contact